199 related articles for article (PubMed ID: 20219963)
1. Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
Vernarelli JA; Roberts JS; Hiraki S; Chen CA; Cupples LA; Green RC
Am J Clin Nutr; 2010 May; 91(5):1402-7. PubMed ID: 20219963
[TBL] [Abstract][Full Text] [Related]
2. Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.
Waterink L; Masselink LA; van der Lee SJ; Visser LNC; Cleutjens S; van der Schaar J; van Harten AC; Scheltens P; Sikkes SAM; van der Flier WM; Zwan MD
Alzheimers Res Ther; 2024 Jan; 16(1):1. PubMed ID: 38167083
[TBL] [Abstract][Full Text] [Related]
3. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
4. Disclosure of APOE genotype for risk of Alzheimer's disease.
Green RC; Roberts JS; Cupples LA; Relkin NR; Whitehouse PJ; Brown T; Eckert SL; Butson M; Sadovnick AD; Quaid KA; Chen C; Cook-Deegan R; Farrer LA;
N Engl J Med; 2009 Jul; 361(3):245-54. PubMed ID: 19605829
[TBL] [Abstract][Full Text] [Related]
5. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
[TBL] [Abstract][Full Text] [Related]
6. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
7. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
10. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
Tang MX; Stern Y; Marder K; Bell K; Gurland B; Lantigua R; Andrews H; Feng L; Tycko B; Mayeux R
JAMA; 1998 Mar; 279(10):751-5. PubMed ID: 9508150
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
13. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
Blue EE; Cheng A; Chen S; Yu CE;
JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
[TBL] [Abstract][Full Text] [Related]
14. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.
Evans DA; Bennett DA; Wilson RS; Bienias JL; Morris MC; Scherr PA; Hebert LE; Aggarwal N; Beckett LA; Joglekar R; Berry-Kravis E; Schneider J
Arch Neurol; 2003 Feb; 60(2):185-9. PubMed ID: 12580702
[TBL] [Abstract][Full Text] [Related]
16. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
Irie F; Fitzpatrick AL; Lopez OL; Kuller LH; Peila R; Newman AB; Launer LJ
Arch Neurol; 2008 Jan; 65(1):89-93. PubMed ID: 18195144
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.
Hall K; Murrell J; Ogunniyi A; Deeg M; Baiyewu O; Gao S; Gureje O; Dickens J; Evans R; Smith-Gamble V; Unverzagt FW; Shen J; Hendrie H
Neurology; 2006 Jan; 66(2):223-7. PubMed ID: 16434658
[TBL] [Abstract][Full Text] [Related]
18. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.
Christensen KD; Roberts JS; Whitehouse PJ; Royal CD; Obisesan TO; Cupples LA; Vernarelli JA; Bhatt DL; Linnenbringer E; Butson MB; Fasaye GA; Uhlmann WR; Hiraki S; Wang N; Cook-Deegan R; Green RC;
Ann Intern Med; 2016 Feb; 164(3):155-63. PubMed ID: 26810768
[TBL] [Abstract][Full Text] [Related]
19. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
20. Risk of dementia among white and African American relatives of patients with Alzheimer disease.
Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA;
JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
